Fig. 2From: Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trialGenitourinary and gastrointestinal toxicity by treatmentBack to article page